Citation Impact
Citing Papers
[6]-Gingerol Suppresses Colon Cancer Growth by Targeting Leukotriene A4 Hydrolase
2009
Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis
2019
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
An Integrated Approach for Analysis of the DNA Damage Response in Mammalian Cells
2015 StandoutNobel
Base-excision repair of oxidative DNA damage
2007 StandoutNature
Demethylation of 3-Methylthymine in DNA by Bacterial and Human DNA Dioxygenases
2004 StandoutNobel
Inflammation and cancer
2002 StandoutNature
Cyclooxygenase-2: a potential target in breast cancer
2004
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Bile acids as carcinogens in human gastrointestinal cancers
2004
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours
2003 StandoutNature
15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer
2004
The role of cyclooxygenases in inflammation, cancer, and development
1999
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Leukotriene A4 Hydrolase in Rat and Human Esophageal Adenocarcinomas and Inhibitory Effects of Bestatin
2003
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
Selection of cancer chemopreventive agents based on inhibition of topoisomerase II activity
2000
Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents
1998
PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs
1999
Distribution and function of prostanoid receptors: studies from knockout mice
2000
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
2014 StandoutNature
Imaging in the era of molecular oncology
2008 StandoutNature
Chemoprevention of familial adenomatous polyposis development in the APCmin mouse model by 1,4-phenylene bis(methylene)selenocyanate
2000
The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia
1995
The war on cancer
1996
BRAFE600-associated senescence-like cell cycle arrest of human naevi
2005 StandoutNature
Fructose‐1,6‐diphosphate attenuates prostaglandin E2 production and cyclo‐oxygenase‐2 expression in UVB‐irradiated HaCaT keratinocytes
2002
Calcineurin Promotes Hypoxia-inducible Factor 1α Expression by Dephosphorylating RACK1 and Blocking RACK1 Dimerization
2007 StandoutNobel
The role of p53 in tumour suppression: lessons from mouse models
1999
Ca2+/Calmodulin Kinase-dependent Activation of Hypoxia Inducible Factor 1 Transcriptional Activity in Cells Subjected to Intermittent Hypoxia
2004 StandoutNobel
Molecular mechanism of the chemopreventive effect of resveratrol
2003
The Hallmarks of Cancer
2000 Standout
Lessons from Hereditary Colorectal Cancer
1996 Standout
Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor
2002
Chemoprevention of Colon Cancer by Organoselenium Compounds and Impact of High- or Low-Fat Diets
1997
Micromanaging aging with miRNAs
2011
Will mandatory folic acid fortification prevent or promote cancer?
2004
Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions
2008 StandoutNature
New approaches to understanding p53 gene tumor mutation spectra
1999
Hallmarks of senescence in carcinogenesis and cancer therapy
2004
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
Prostaglandin E2 Induces Hypoxia-inducible Factor-1α Stabilization and Nuclear Localization in a Human Prostate Cancer Cell Line
2002
Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kγ
2000 StandoutNatureNobel
Regulation of Ferroptotic Cancer Cell Death by GPX4
2014 Standout
Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δ
2004
Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention
2001
The microenvironment of the tumour–host interface
2001 StandoutNature
Immunity, Inflammation, and Cancer
2010 Standout
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
1997 Standout
Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2
2000 Standout
The promise of retinoids to fight against cancer
2001
Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)
1996 Standout
Chemoprevention of gastrointestinal cancer
1997
Eicosanoids and cancer
2010 Standout
Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylase
1995
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
1994 StandoutNobel
Honokiol, a Small Molecular Weight Natural Product, Inhibits Angiogenesis in Vitro and Tumor Growth in Vivo
2003 Standout
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Insight into prostaglandin, leukotriene, and other eicosanoid functions using mice with targeted gene disruptions☆
1999
Rejuvenation of aged progenitor cells by exposure to a young systemic environment
2005 StandoutNature
The Hallmarks of Aging
2013 Standout
Green Tea Constituent Epigallocatechin-3-Gallate and Induction of Apoptosis and Cell Cycle Arrest in Human Carcinoma Cells
1997 Standout
Development of novel therapeutic strategies that target HIF-1
2006 StandoutNobel
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
2003 StandoutNature
Selenium in Cancer Prevention: Clinical Issues and Implications
2001
Topical chemoprevention of skin cancer in mice, using combined inhibitors of 5-lipoxygenase and cyclo-oxygenase-2
2009
Roles of PPARs in health and disease
2000 StandoutNature
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
2001
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Localization of the glucocorticoid receptor in discrete clusters in the cell nucleus
1995
Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin.
1996 StandoutNobel
Lipoxygenase and Leukotriene Pathways: Biochemistry, Biology, and Roles in Disease
2011
Molecular insights into cancer invasion: strategies for prevention and intervention.
1995
Nonsteroidal Anti-Inflammatory Drugs and Cancer Prevention
2000
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1.
2003 StandoutNobel
Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma.
1984 StandoutNobel
The Fourth DeWitt S. Goodman lecture. Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention.
2000
Mitochondrial DNA Mutations, Oxidative Stress, and Apoptosis in Mammalian Aging
2005 StandoutScience
Life‐long calorie restriction (CR) increases expression of apoptosis repressor with a caspase recruitment domain (ARC) in the brain
2003
Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene
1983 Nature
Formaldehyde Carcinogenicity Research
2012
Aging and Genome Maintenance: Lessons from the Mouse?
2003 Science
Characteristics of Selenazolidine Prodrugs of Selenocysteine: Toxicity and Glutathione Peroxidase Induction in V79 Cells
2003
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Myh Deficiency Enhances Intestinal Tumorigenesis in Multiple Intestinal Neoplasia ( Apc Min /+) Mice
2004
Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols
2001
Role of prostaglandin E 2 -dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression
2003
Optical Markers in Duodenal Mucosa Predict the Presence of Pancreatic Cancer
2007
The Ecology of Arsenic
2003 StandoutScience
Metabolic reprogramming and cancer progression
2020 StandoutScience
Surfing the p53 network
2000 StandoutNature
Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
1997 StandoutScience
Overexpression of 5-Lipoxygenase in Rat and Human Esophageal Adenocarcinoma and Inhibitory Effects of Zileuton and Celecoxib on Carcinogenesis
2004
Colon cancer chemopreventive drugs modulate integrin-mediated signaling pathways.
2000
Tissue-specific contributions of Tmem79 to atopic dermatitis and mast cell-mediated histaminergic itch
2018 StandoutNobel
Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2
2001 StandoutNobel
Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.
1999
Arsenic alters the function of the glucocorticoid receptor as a transcription factor.
2001
In vitro transformation of human epithelial cells
1986
Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin
1997
Organoselenium and Organotellurium Compounds: Toxicology and Pharmacology
2004 Standout
Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
2001
Prevention--therapy--basic science and the resolution of the cancer problem.
1993
Works of Vernon E. Steele being referenced
Mechanistic considerations in chemopreventive drug development
1994
Growth kinetics and chemoprevention of aberrant crypts in the rat colon
1992
Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer
2001
K-ras mutations in lung tumors from A/J and A/J×TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate
1995
Use ofin vitro assays to predict the efficacy of chemopreventive agents in whole animals
1996
Screening for chemopreventive (anticarcinogenic) compounds in rodents
1992
Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents
1994
Progress in Cancer Chemoprevention: Development of Diet-Derived Chemopreventive Agents
2000
Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: Methods and results from the NCI chemoprevention drug development program
1994
Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer
2003
Chemopreventive agents induce a senescence-like phenotype in rat mammary tumours
2002
N -(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1 -mutated breast cancer cells
2005
Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL‐KrasG12D/+ mice
2012
Chemoprevention of Prostate Cancer: Concepts and Strategies
1999
Chemopreventive efficacy of anethole trithione, N-acetyl-L-cysteine, miconazole and phenethylisothiocyanate in the DMBA-induced rat mammary cancer model
1997
Guidance for development of chemopreventive agents
1994
Intermediate biomarkers of precancer and their application in chemoprevention
1992
Chemopreventive drug development: perspectives and progress.
1994
Lack of chemopreventive efficacy of DL-selenomethionine in colon carcinogenesis.
2000
Chemoprevention of OH-BBN-induced bladder cancer in mice by oltipraz, alone and in combination with 4-HPR and DFMO.
1994
Transformation of tracheal epithelium exposed in vitro to N‐methyl‐N′‐nitro‐N‐nitrosoguanidine (MNNG)
1977
Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
1997
Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
1995
Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
2000
Neoplastic transformation of primary tracheal epithelial cell cultures
1983
Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke
2008
Risk biomarkers and current strategies for cancer chemoprevention
1996
Effects of novel phenylretinamides on cell growth and apoptosis in bladder cancer.
2001
Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
1994
Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives.
1996
Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression
2000
Chemoprevention by lipoxygenase and leukotriene pathway inhibitors of vinyl carbamate-induced lung tumors in mice.
2002
Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy
1992
In situ detection of neoplastic transformation and chemopreventive effects in rat esophagus epithelium using angle-resolved low-coherence interferometry.
2003
Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light
2009
Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat.
1996
Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.
1999
Approaches to the development and marketing approval of drugs that prevent cancer.
1995
Chemoprevention of colon carcinogenesis by dietary perillyl alcohol.
1997
Induction of apoptosis by 1,4-phenylenebis(methylene)selenocyanate in cultured human colon cancer cells.
2002
Enhancement of experimental colon cancer by genistein.
1997
Lipoxygenase inhibitors as potential cancer chemopreventives.
1999
Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
1999
Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice.
1997
New agents for cancer chemoprevention
1996